FDA Drug Application (022024) for ACTOPLUS MET XR by TAKEDA PHARMS USA

Back to FDA Applications sponsored by TAKEDA PHARMS USA

Application Number022024
Product Number001
FormTABLET, EXTENDED RELEASE;ORAL
Dosage1GM;EQ 15MG BASE
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameACTOPLUS MET XR
Active IngredientMETFORMIN HYDROCHLORIDE; PIOGLITAZONE HYDROCHLORIDE

Active IngredientCount
List of drugs with Active Ingredient METFORMIN HYDROCHLORIDE32
List of drugs with Active Ingredient PIOGLITAZONE HYDROCHLORIDE9


Back to FDA Applications sponsored by TAKEDA PHARMS USA